Updated:
DICE Therapeutics, Inc.
DICE Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001645569, and its reported industry...
Overview
DICE Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001645569, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-15, it reported net income of USD -83,887,000; total assets of USD 593,978,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- DICE Therapeutics, Inc.
- Former names in filing history
- DiCE Molecules Holdings, LLC (2018-07-25 to 2021-09-10); DiCE MOLECULES HOLDINGS, LLC (2018-07-25 to 2021-09-10)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 30
- SEC CIK
- 0001645569
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | — | -$83.9M | $594.0M | $461.4M | -$64.3M | |
| FY2021USD | $1.1M | -$49.0M | $325.8M | $115.8M | -$39.3M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| SC 13G | — | Form SC 13G | |
| SC 13G | — | DICE THERAPEUTICS, INC. | |
| SC 13G | — | Form SC 13G |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research DICE Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.